SynBioBeta Speaker
Beatrix Ellis
CEO
GitLife Biotech
SynBioBeta 2025 - Session Speaker
Scaling SynBio: Investment Strategies from Lab to Market
Transitioning synthetic biology innovations from the lab to commercial scale requires strategic investment, robust infrastructure, and cross-sector collaboration. This session explores the financial and operational challenges of scaling the bioeconomy in the UK and Europe, highlighting key funding mechanisms, investor perspectives, and case studies of successful scale-ups. Join this session to understand the investment landscape, technology readiness, and market adoption and hear insights for startups and stakeholders looking to bridge the gap between research and commercialization.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
21:16:19:27
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates